Johannes Notni

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Topics

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecular pharmaceutics

RSC medicinal chemistry

EJNMMI research

This page only lists publications with an associated author ORCID identifier.

Publications

Neil Gerard Quigley, Katja Steiger, Stefanie Felicitas Färber, Frauke Richter, Wilko Weichert, Johannes Notni
Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12. Molecular pharmaceutics (2024)
Neil Gerard Quigley, Katja Steiger, Stefanie Felicitas Färber, Frauke Richter, Wilko Weichert, Johannes Notni
Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12. Molecular pharmaceutics 21 (4) (2024)
Neil Gerard Quigley, Katja Steiger, Stefanie Felicitas Färber, Frauke Richter, Wilko Weichert, Johannes Notni
Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12. Molecular pharmaceutics (2024)
Neil Gerard Quigley, Katja Steiger, Stefanie Felicitas Färber, Frauke Richter, Wilko Weichert, Johannes Notni
Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12. Molecular pharmaceutics 21 (4) (2024)
Stefan Stangl, Nghia Trong Nguyen, Julia Brosch-Lenz, Jakub Šimeček, Wolfgang A Weber, Susanne Kossatz, Johannes Notni
Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles. European journal of nuclear medicine and molecular imaging 51 (11) (2024)
Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig, Frauke Richter, Nghia Trong Nguyen, Falco Reissig, Jakub Šimeček, Susanne Kossatz, Johannes Notni
The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics. RSC medicinal chemistry 15 (6) (2024)
Neil Gerard Quigley, Maximilian Alexander Zierke, Beatrice Stefanie Ludwig, Frauke Richter, Nghia Trong Nguyen, Falco Reissig, Jakub Šimeček, Susanne Kossatz, Johannes Notni
The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics. RSC medicinal chemistry 15 (6) (2024)
Stefan Stangl, Nghia Trong Nguyen, Julia Brosch-Lenz, Jakub Šimeček, Wolfgang A Weber, Susanne Kossatz, Johannes Notni
Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles. European journal of nuclear medicine and molecular imaging (2024)
Neil Gerard Quigley, Frauke Richter, Susanne Kossatz, Johannes Notni
Complexity of αvβ6-integrin targeting RGD peptide trimers: emergence of non-specific binding by synergistic interaction. RSC medicinal chemistry 14 (12) (2023)
Stephan Settelmeier, Zohreh Varasteh, Magdalena Staniszewska, Anna-Lena Beerlage, Fadi Zarrad, Wolfgang P Fendler, Christoph Rischpler, Johannes Notni, Matthias Totzeck, Ken Herrmann, Tienush Rassaf, Ulrike B Hendgen-Cotta
Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Neil Gerard Quigley, Frauke Richter, Susanne Kossatz, Johannes Notni
Complexity of αvβ6-integrin targeting RGD peptide trimers: emergence of non-specific binding by synergistic interaction. RSC medicinal chemistry 14 (12) (2023)
Stephan Settelmeier, Zohreh Varasteh, Magdalena Staniszewska, Anna-Lena Beerlage, Fadi Zarrad, Wolfgang P Fendler, Christoph Rischpler, Johannes Notni, Matthias Totzeck, Ken Herrmann, Tienush Rassaf, Ulrike B Hendgen-Cotta
Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Johannes Notni
RGD Forever!-Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Johannes Notni
RGD Forever!-Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Johannes Notni
RGD Forever!-Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Johannes Notni
RGD Forever!-Past, Present, and Future of a 3-Letter-Code in Radiopharmacy and Life Sciences. Pharmaceuticals (Basel, Switzerland) 16 (1) (2022)
Neil Gerard Quigley, Katja Steiger, Sebastian Hoberück, Norbert Czech, Maximilian Alexander Zierke, Susanne Kossatz, Marc Pretze, Frauke Richter, Wilko Weichert, Christian Pox, Jörg Kotzerke, Johannes Notni
PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin. European journal of nuclear medicine and molecular imaging (2021)
Neil Gerard Quigley, Norbert Czech, Wolfgang Sendt, Johannes Notni
PET/CT imaging of pancreatic carcinoma targeting the "cancer integrin" αvβ6. European journal of nuclear medicine and molecular imaging 48 (12) (2021)
Susanne Kossatz, Ambros Johannes Beer, Johannes Notni
It's Time to Shift the Paradigm: Translation and Clinical Application of Non-αvβ3 Integrin Targeting Radiopharmaceuticals. Cancers 13 (23) (2021)
Katja Steiger, Neil Gerard Quigley, Tanja Groll, Frauke Richter, Maximilian Alexander Zierke, Ambros Johannes Beer, Wilko Weichert, Markus Schwaiger, Susanne Kossatz, Johannes Notni
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography. EJNMMI research 11 (1) (2021)
Sebastian Gulde, Tobias Wiedemann, Mathias Schillmaier, Isabel Valença, Amelie Lupp, Katja Steiger, Hsi-Yu Yen, Stephen Bäuerle, Johannes Notni, Raul Miguel Luque, Herbert Schmid, Stefan Schulz, Donna P Ankerst, Franz Schilling, Natalia S Pellegata
Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors. Cancers 13 (12) (2021)
Frank Bruchertseifer, Peter Comba, Bodo Martin, Alfred Morgenstern, Johannes Notni, Miriam Starke, Hubert Wadepohl
First-Generation Bispidine Chelators for 213 BiIII Radiopharmaceutical Applications. ChemMedChem 15 (16) (2020)
Neil Gerard Quigley, Katja Steiger, Frauke Richter, Wilko Weichert, Sebastian Hoberück, Jörg Kotzerke, Johannes Notni
Tracking a TGF-β activator in vivo: sensitive PET imaging of αvβ8-integrin with the Ga-68-labeled cyclic RGD octapeptide trimer Ga-68-Triveoctin. EJNMMI research 10 (1) (2020)
Neil Gerard Quigley, Stefano Tomassi, Francesco Saviero Di Leva, Salvatore Di Maro, Frauke Richter, Katja Steiger, Susanne Kossatz, Luciana Marinelli, Johannes Notni
Click-Chemistry (CuAAC) Trimerization of an αv β6 Integrin Targeting Ga-68-Peptide: Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts. Chembiochem : a European journal of chemical biology 21 (19) (2020)
Eliška Hacaperková, Adam Jaroš, Jan Kotek, Johannes Notni, Michal Straka, Vojtěch Kubíček, Petr Hermann
Al(III)-NTA-fluoride: a simple model system for Al-F binding with interesting thermodynamics. Dalton transactions (Cambridge, England : 2003) 49 (39) (2020)
Johannes Notni, Florian T Gassert, Katja Steiger, Peter Sommer, Wilko Weichert, Ernst J Rummeny, Markus Schwaiger, Horst Kessler, Reinhard Meier, Melanie A Kimm
In vivo imaging of early stages of rheumatoid arthritis by α5β1-integrin-targeted positron emission tomography. EJNMMI research 9 (1) (2019)
Florian Reichart, Oleg V Maltsev, Tobias G Kapp, Andreas F B Räder, Michael Weinmüller, Udaya Kiran Marelli, Johannes Notni, Alexander Wurzer, Roswitha Beck, Hans-Jürgen Wester, Katja Steiger, Salvatore Di Maro, Francesco Saverio Di Leva, Luciana Marinelli, Markus Nieberler, Ute Reuning, Markus Schwaiger, Horst Kessler
Selective Targeting of Integrin αvβ8 by a Highly Active Cyclic Peptide. Journal of medicinal chemistry 62 (4) (2019)
Dominik Reich, Alexander Wurzer, Martina Wirtz, Veronika Stiegler, Philipp Spatz, Julia Pollmann, Hans-Jürgen Wester, Johannes Notni
Dendritic poly-chelator frameworks for multimeric bioconjugation. Chemical communications (Cambridge, England) 53 (17) (2018)
Soňa Procházková, Vojtěch Kubíček, Jan Kotek, Adrienn Vágner, Johannes Notni, Petr Hermann
Lanthanide(iii) complexes of monophosphinate/monophosphonate DOTA-analogues: effects of the substituents on the formation rate and radiolabelling yield. Dalton transactions (Cambridge, England : 2003) 47 (37) (2018)
Tobias G Kapp, Francesco Saverio Di Leva, Johannes Notni, Andreas F B Räder, Maximilian Fottner, Florian Reichart, Dominik Reich, Alexander Wurzer, Katja Steiger, Ettore Novellino, Udaya Kiran Marelli, Hans-Jürgen Wester, Luciana Marinelli, Horst Kessler
N-Methylation of isoDGR Peptides: Discovery of a Selective α5β1-Integrin Ligand as a Potent Tumor Imaging Agent. Journal of medicinal chemistry 61 (6) (2018)
Alexander Wurzer, Julia Pollmann, Alexander Schmidt, Dominik Reich, Hans-Jürgen Wester, Johannes Notni
Molar Activity of Ga-68 Labeled PSMA Inhibitor Conjugates Determines PET Imaging Results. Molecular pharmaceutics 15 (9) (2018)
Jakub Šimeček, Petr Hermann, Christof Seidl, Frank Bruchertseifer, Alfred Morgenstern, Hans-Jürgen Wester, Johannes Notni
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics. EJNMMI research 8 (1) (2018)
Anja Wacker, Fabio Carniato, Carlos Platas-Iglesias, David Esteban-Gomez, Hans-Jürgen Wester, Lorenzo Tei, Johannes Notni
Dimer formation of GdDO3A-arylsulfonamide complexes causes loss of pH-dependency of relaxivity. Dalton transactions (Cambridge, England : 2003) 46 (48) (2018)
Francesco Saverio Di Leva, Stefano Tomassi, Salvatore Di Maro, Florian Reichart, Johannes Notni, Abha Dangi, Udaya Kiran Marelli, Diego Brancaccio, Francesco Merlino, Hans-Jürgen Wester, Ettore Novellino, Horst Kessler, Luciana Marinelli
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands. Angewandte Chemie (International ed. in English) 57 (44) (2018)
Alexander Wurzer, Christof Seidl, Alfred Morgenstern, Frank Bruchertseifer, Markus Schwaiger, Hans-Jürgen Wester, Johannes Notni
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy. Chemistry (Weinheim an der Bergstrasse, Germany) 24 (3) (2017)
Johannes Notni, Hans-Jürgen Wester
Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals. Journal of labelled compounds & radiopharmaceuticals 61 (3) (2017)